ISSDP

The International Society for the Study of Drug Policy

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
The International Society for the Study of Drug Policy
English Español
  • Conferences & Events
    • Future Conferences & Events
    • Past Conferences & Events
    • Webinars
    • Past Webinars
    • Webinar Recordings (for Members)
  • News and Announcements
    • Current News & Announcements
    • Newsletters
    • Archived News & Announcements
  • Bibliography
    • Introduction
    • All Publications
    • Bibliography Archive
    • Prevalence
    • Production and Supply
    • Economics
    • Domestic Policy Issues
    • International Policy Issues
    • Interventions – Prevention
    • Interventions – Treatment
    • Interventions – Law Enforcement
    • Interventions – Harm Reduction
  • Membership
  • Who we are
  • Working Group
  • By-laws
  • Annual Awards
  • IJDP

Bibliography: Prevalence


Results and challenges of running the Web Survey on Drugs in Luxembourg: a major contribution to understanding the drug situation

7th November 2022

This paper shows how the second wave of the European Web Survey on Drugs (EWSD) led to a better understanding of the drug situation in Luxembourg. Until the EWSD, detailed information on the drug situation in Luxembourg was very limited, with only a few surveys, often small-scale, having been conducted in the country since the late 1990s (EMCDDA)

Categories: Bibliography, International Policy Issues, Prevalence

Categories: International Policy Issues, Prevalence

New report finds 171 drug-related hospitalisations per day in Australia in 2020-21

3rd November 2022

There were 62,486 drug-related hospitalisations (excluding alcohol and tobacco) among Australians in 2020-21, according to a new report released today by the Drug Trends program at the National Drug and Alcohol Research Centre (NDARC), UNSW Sydney

Categories: Bibliography, Prevalence

Categories: Prevalence

Harm Reduction Database Wales: Drug related mortality

28th October 2022

Annual Report 2021-22 – PowerPoint (Public Health Wales)

Categories: Bibliography, Prevalence

Categories: Prevalence

New report finds 171 drug-related hospitalisations per day in Australia in 2020-21

27th October 2022

There were 62,486 drug-related hospitalisations (excluding alcohol and tobacco) among Australians in 2020-21, according to a new report released today by the Drug Trends program at the National Drug and Alcohol Research Centre (NDARC), UNSW Sydney

Categories: Bibliography, Prevalence

Categories: Prevalence

Wales’ drug deaths a complex picture

20th October 2022

A complex and evolving pattern of drug use and availability is resulting in increased drug deaths in Wales, with two thirds of deaths in 2021 involving a combination of drugs, including alcohol and prescription medicines Download (Public Health Wales)

Categories: Bibliography, Interventions - Harm Reduction, Prevalence

Categories: Interventions - Harm Reduction, Prevalence

Problematic opioid use in Ireland, 2015–2019

13th October 2022

In this report, we present the results of a study that aimed to estimate the prevalence of problematic opioid use in Ireland from 2015 to 2019 using a four-source capture-recapture method. Three of the four data sources used for the analysis were derived from opioid substitution treatment records from the Central Treatment List (CTL) (clinics, general practitioners (GPs) and prisons) and the fourth data source was derived from the Probation Service (HRB National Drugs Library)

Categories: Bibliography, Prevalence

Categories: Prevalence

New Report Recommends 34 Indicators to Improve Measuring the Impact of Drug-Impaired Driving Across Canada

30th September 2022

A new report released today by the Canadian Centre on Substance Use and Addiction (CCSA) recommends 34 indicators (e.g., collecting anonymous data on the potential presence and types of drugs in hospitalized drivers) to better measure the impact of DID across Canada

Categories: Bibliography, Prevalence

Categories: Prevalence

Australian Drug Trends 2022: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews

27th September 2022

his includes:

A report overviewing the key findings in 2022;
An infographic summarising key findings in 2022;
A methods document highlighting approaches to collating and presenting estimates; and
The executive summary, summarising key findings in 2022.

Categories: Bibliography, Prevalence

Categories: Prevalence

Smoking, Drinking and Drug Use among Young People in England, 2021

7th September 2022

This report contains results from the latest survey of secondary school pupils in England in years 7 to 11 (mostly aged 11 to 15), focusing on smoking, drinking and drug use. It covers a range of topics including prevalence, habits, attitudes, and wellbeing (NHS)

Categories: Bibliography, Prevalence

Categories: Prevalence

Australia’s Annual Overdose Report

31st August 2022

Penington Institute publishes Australia’s Annual Overdose Report, the most comprehensive and ambitious study of overdose in Australia

Categories: Bibliography, Interventions - Harm Reduction, Prevalence

Categories: Interventions - Harm Reduction, Prevalence

Scottish Drug Deaths Taskforce Evidence Paper

25th August 2022

The evidence presented and summarised in this paper is split into sections on topics relevant to the research and evidence gathered in preparation for our final report Changing Lives (Deaths Taskforce)

Categories: Bibliography, Prevalence

Categories: Prevalence

Delving deeper into the social health of people who use methamphetamine

24th August 2022

A large 2019 survey estimated that 300,000 Australians aged 14 years and over had used some form of illicit meth/amphetamine in the previous year. Half had used the crystal form of methamphetamine (“ice”), and one-fifth had used the powdered form “speed” (Monash University)

Categories: Bibliography, Prevalence

Categories: Prevalence

People who inject drugs: HIV and viral hepatitis monitoring

12th August 2022

Data tables and commentary for the unlinked anonymous monitoring surveys of infections and risk among people who inject drugs (UK Health Security Agency)

Categories: Bibliography, Prevalence

Categories: Prevalence

European Drug Report 2022: Trends and Developments

5th August 2022

The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions (EMCDDA)

Categories: Bibliography, International Policy Issues, Prevalence, Production and Supply

Categories: International Policy Issues, Prevalence, Production and Supply

Trends in the availability and type of drugs sold on the internet via cryptomarkets, June 2021 – May 2022

5th August 2022

This bulletin series reports on trends in the availability and types of drugs sold on the internet via cryptomarkets over a 12-month period (a new bulletin is released typically every 4 months). The current bulletin focuses on analysis of drug listings on cryptomarkets from 1st June 2021 to 31st May 2022 (NDARC)

Categories: Bibliography, Prevalence

Categories: Prevalence

Deaths related to drug poisoning in England and Wales: 2021 registrations

3rd August 2022

Deaths related to drug poisoning in England and Wales from 1993 to 2021, by cause of death, sex, age and substances involved in the death (Office of National Statistics)

Categories: Bibliography, Prevalence

Categories: Prevalence

The Global Cannabis Cultivation Research Consortium (GCCRC): a transnational online survey of cannabis growers

29th July 2022

This paper presents some of the key findings of an innovative online survey of cannabis growers in Europe, Australia and North America. The International Cannabis Cultivation Questionnaire (ICCQ) present generated important findings about cannabis cultivation, along with policy insights and methodological lessons that would likely have been unattainable through other methods (EMCDDA)

Categories: Bibliography, Prevalence, Production and Supply

Categories: Prevalence, Production and Supply

Drug-related Deaths in Scotland in 2021

28th July 2022

Statistics of drug-related deaths in 2021 and earlier years, broken down by age, sex, substances implicated in the death, underlying cause of death, and NHS Board and Council areas (National Records of Scotland)

Categories: Bibliography, Interventions - Harm Reduction, Prevalence

Categories: Interventions - Harm Reduction, Prevalence

Urban–Rural Differences in Drug Overdose Death Rates, 2020

21st July 2022

Drug overdose death rates, which have been rising over the past decade, differ by urban and rural counties across the United States (CDC)

Categories: Bibliography, Prevalence

Categories: Prevalence

Overdose death rates increased significantly for Black, American Indian/Alaska Native people in 2020

20th July 2022

Recent increases in deaths largely driven by illicitly manufactured fentanyl (CDC)

Categories: Bibliography, Prevalence

Categories: Prevalence
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 32
  • Next Page »

Search the Bibliography

Bibliography Menu

  • Introduction
  • All Publications
  • Prevalence
  • Production and Supply
  • Economics
  • Domestic Policy Issues
  • International Policy Issues
  • Interventions – Prevention
  • Interventions – Treatment
  • Interventions – Law Enforcement
  • Interventions – Harm Reduction

Bibliography Archive

calendar-iconBibliography Archive ››

Navigation

  • Home
  • Future Conferences & Events
  • News & Announcements
  • Bibliography
  • Working Group
  • Annual Awards
  • Membership
  • Who we are
  • By-laws
  • IJDP
  • Contact

ISSDP on Twitter

Tweets by @ISSDrugPolicy

Contact ISSDP

For further information about the ISSDP, including membership queries, please contact us.

Please Share ISSDP

Copyright © 2023 The International Society for the Study of Drug Policy

The International Society for the Study of Drug Policy is registered in England as a charitable incorporated organisation. Charity no: 1177654